Related Experiment Video

Updated: Jul 20, 2026

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
19:15

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale

Published on: August 25, 2014

Declining blood lead levels and cognitive changes in moderately lead-poisoned children

H A Ruff1, P E Bijur, M Markowitz

  • 1Department of Pediatrics, Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, NY.

JAMA
|April 7, 1993
PubMed

Insights

Reducing blood lead levels in children with moderate lead poisoning is linked to improved cognitive function over time. This study found cognitive scores increased as blood lead levels decreased, suggesting a beneficial association.

Area of Science:

  • Pediatric Environmental Health
  • Neurodevelopmental Toxicology
  • Public Health Interventions

Background:

  • Lead poisoning remains a significant public health concern for children.
  • Cognitive deficits are a known consequence of lead exposure.
  • Understanding the impact of lead-lowering interventions on cognitive outcomes is crucial.

Purpose of the Study:

  • To investigate the association between chelation therapy and biochemical changes during lead reduction interventions and cognitive function in children.
  • To test the hypothesis that cognitive performance improves with declining blood lead levels.

Main Methods:

  • A short-term intervention study involving 154 children (13-87 months) with moderate lead poisoning (blood lead levels 1.21-2.66 mumol/L).
  • Interventions included edetate calcium disodium (EDTA) and iron supplementation, alongside housing abatement.
  • Cognitive function was assessed using the Bayley Mental Development Scale or Stanford-Binet Intelligence Scale before and after intervention.

Main Results:

  • Edetate calcium disodium treatment alone showed no significant effect in the short term.
  • Short-term (7 weeks) changes in blood lead levels were not correlated with cognitive score changes.
  • Long-term (6 months) improvements in cognitive scores were significantly associated with decreases in blood lead levels (1 point increase per 0.14 mumol/L decrease).

Conclusions:

  • Decreases in blood lead levels are associated with cognitive improvements in children with moderate lead poisoning.
  • The findings support the importance of lead-lowering interventions for neurodevelopmental recovery.
  • Long-term follow-up is essential to observe the full impact of interventions on cognitive function.
Abstract

More Related Videos

Moderate Prenatal Alcohol Exposure and Quantification of Social Behavior in Adult Rats11:01

Moderate Prenatal Alcohol Exposure and Quantification of Social Behavior in Adult Rats

Published on: December 14, 2014

The Use of Trace Eyeblink Classical Conditioning to Assess Hippocampal Dysfunction in a Rat Model of Fetal Alcohol Spectrum Disorders19:57

The Use of Trace Eyeblink Classical Conditioning to Assess Hippocampal Dysfunction in a Rat Model of Fetal Alcohol Spectrum Disorders

Published on: August 5, 2017

Related Concept Videos

Long-term Depression01:03

Long-term Depression

Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over time, all...
CNS Depressants: Alcohol and Nicotine01:27

CNS Depressants: Alcohol and Nicotine

Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Intellectual Disability01:29

Intellectual Disability

Intellectual disability (ID) is a neurodevelopmental condition characterized by deficits in intellectual and adaptive functioning that manifest during the developmental period. This condition encompasses challenges in reasoning, memory, problem-solving, and learning, accompanied by impairments in everyday life skills, such as communication, self-care, and social interactions. Intellectual disability affects approximately 1% of the population in the United States, impacting an estimated 5...